您的购物车当前为空
别名 SPD-758, SGX-145, SGX145, beta-L-OddC, BCH-4556, BCH4556
Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious against Panc-01.

Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious against Panc-01.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,370 | 5日内发货 | |
| 5 mg | ¥ 2,520 | 5日内发货 |
| 产品描述 | Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious against Panc-01. |
| 别名 | SPD-758, SGX-145, SGX145, beta-L-OddC, BCH-4556, BCH4556 |
| 分子量 | 213.19 |
| 分子式 | C8H11N3O4 |
| CAS No. | 145918-75-8 |
| 密度 | 1.71 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: Soluble H2O: Insoluble |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多